Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient.
Luke M LewisAlice L TangTrisha M Wise-DraperKasiani C MyersJoel S GreenbergerVinita TakiarPublished in: Head & neck (2020)
The FA patient population has a clear need for adjuvant treatment regimens given their predilection for HNSCC. A therapeutic trial may allow FA and other radiosensitive patients to trial radiation with the option to terminate treatment before any severe side effects occur and for some to complete a full course of treatment.